Auth bypass in Medtronic Minimed 508

CVE-2019-10964

Medtronic MiniMed Insulin Pumps are designed to communicate using a wireless RF with other devices, such as blood glucose meters, glucose sensor transmitters, and CareLink USB devices. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with adjacent access to one of the affected insulin pump models can inject, replay, modify, and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.

Published · last modified .

CVSS v3 metric

CVSS v3 base score 7.1 (High). Vector: CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:U/C:L/I:H/A:H.

EPSS exploit prediction

EPSS: 0.012 (67.9th percentile), scored .

Low probability of exploitation in the next 30 days, but still tracked. 68th percentile — 67.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2019-10964: held from 0.012 to 0.012.

EPSS over last 30 days · oldest: 0.012 · newest: 0.012 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2019-10964?
CVE-2019-10964 is a high-severity vulnerability in Medtronic Minimed 508, classified under Improper Access Control. CVSS score: 7.1/10. Published 2019-06-28.
How severe is CVE-2019-10964?
High severity. CVSS v3 base score is 7.1 out of 10.